Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion type Assertion NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_head.
- NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion description "[To determine the maximum tolerated dose (MTD) of the oral mTOR inhibitor everolimus in advanced HCC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_provenance.
- NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion evidence source_evidence_literature NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_provenance.
- NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion SIO_000772 23134470 NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_provenance.
- NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion wasDerivedFrom befree-20140225 NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_provenance.
- NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_assertion wasGeneratedBy ECO_0000203 NP390229.RA7yg9K7HJ84wNRUQfdTa-TjN7M3bvXJda_1Qlbjl7r9M130_provenance.